These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7828367)

  • 1. Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus.
    Theocharis S; Sfikakis PP; Lipnick RN; Klipple GL; Steinberg AD; Tsokos GC
    Clin Immunol Immunopathol; 1995 Feb; 74(2):135-42. PubMed ID: 7828367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
    Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
    Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus.
    Gmelig-Meyling F; Dawisha S; Steinberg AD
    J Exp Med; 1992 Jan; 175(1):297-300. PubMed ID: 1730923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
    Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
    Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production.
    Voll RE; Roth EA; Girkontaite I; Fehr H; Herrmann M; Lorenz HM; Kalden JR
    Arthritis Rheum; 1997 Dec; 40(12):2162-71. PubMed ID: 9416853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
    Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
    Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of in vivo hprt gene-mutated T cells in the peripheral blood of patients with systemic sclerosis.
    Sfikakis PP; Tesar J; Theocharis S; Klipple GL; Tsokos GC
    Ann Rheum Dis; 1994 Feb; 53(2):122-7. PubMed ID: 8129457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of clinical parameters associated with increased frequency of mutant T cells in patients with systemic lupus erythematosus.
    Dawisha SM; Gmelig-Meyling F; Steinberg AD
    Arthritis Rheum; 1994 Feb; 37(2):270-7. PubMed ID: 8129782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals.
    Hoffman RW; Takeda Y; Sharp GC; Lee DR; Hill DL; Kaneoka H; Caldwell CW
    J Immunol; 1993 Dec; 151(11):6460-9. PubMed ID: 8245479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
    Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production.
    Takeno M; Nagafuchi H; Kaneko S; Wakisaka S; Oneda K; Takeba Y; Yamashita N; Suzuki N; Kaneoka H; Sakane T
    J Immunol; 1997 Apr; 158(7):3529-38. PubMed ID: 9120315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus.
    Crow MK; DelGiudice-Asch G; Zehetbauer JB; Lawson JL; Brot N; Weissbach H; Elkon KB
    J Clin Invest; 1994 Jul; 94(1):345-52. PubMed ID: 7913711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of anti-lymphocyte antibody in patients with active SLE. II. Effect of anti-lymphocyte antibody on autoreactive cell clones.
    Morimoto C; Abe T; Toguchi T; Kiyotaki M; Homma M
    Scand J Immunol; 1980; 11(5):479-88. PubMed ID: 6966821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro T-cell functions specific to an anti-DNA idiotype and serological markers in patients with systemic lupus erythematosus (SLE).
    Mendlovic S; Shoenfeld Y; Bakimer R; Segal R; Dayan M; Mozes E
    J Clin Immunol; 1988 May; 8(3):178-87. PubMed ID: 2455730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: implications for T cell proliferation in HIV disease.
    Paganin C; Monos DS; Marshall JD; Frank I; Trinchieri G
    J Clin Invest; 1997 Feb; 99(4):663-8. PubMed ID: 9045868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.